| HOME >> MEDICINE >> TECHNOLOGY |
Figure 11: Cambrex's fine chemicals sales ($m), 2010 70
Figure 12: DSM's pharmaceutical division net sales ($m), 2010 74
Figure 13: Evonik's chemical division net sales ($m), 2010 78
Table of tables
Table 1: Differentiating characteristics of commodities, fine chemicals and specialty chemicals 17
Table 2: List of important basic pharmaceutical intermediates and their applications 19
Table 3: List of major natural sources used in the synthesis of APIs 23
Table 4: List of major petrochemical products used in the synthesis of APIs 23
Table 5: Global pharmaceutical market by country ($m), 2009 36
Table 6: Forecast sales performance of pharmaceutical fine chemicals, 2010–2015 39
Table 7: Patent expiries of key pharmaceutical compounds during 2010–2015 50
Table 8: Performance of leading PFC companies ($m), 2009 60
Table 9: BASF financial performance by segment ($m), 2009 66
Table 10: Boehringer Ingelheim financial performance by segment ($m), 2009 68
Table 11: DSM financial performance by segment ($m), 2009 73
Table 12: Evonik's Chemical division sales ($m), 2009 77
Table 13: Lonza financial performance ($m), 2009 80
To order this report:
: The Global Pharmaceutical Fine Chemicals Market Outlook to 2015
Check our Company Profile, SWOT and Revenue Analysis!
CONTACT
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |